Using a Revenue DCF model with operating margin convergence from -35.3% to a target of 23.6% over 5 years, discounted at a WACC of 7.4%, U.S. Global Investors, Inc. (GROW) has an intrinsic value of $2.31 per share (range: $1.95 – $3.24).
Using a Revenue DCF model with operating margin convergence from -35.3% to a target of 23.6% over 5 years, discounted at a WACC of 7.4%, U.S. Global Investors, Inc. (GROW) has an intrinsic value of $2.58 per share (range: $2.02 – $4.07).
Using the industry peer median EV/Revenue multiple (trailing + forward), U.S. Global Investors, Inc. (GROW) has a fair value of $4.35 based on 7 comparable companies in the Asset Management - Global industry.
USD in millions except Fair Price. Subject company highlighted.
| Mkt Cap ($M) | Trailing EV/Revenue | Forward EV/Revenue | |
|---|---|---|---|
| U.S. Global Investors, Inc.GROW | 35 | 1.2x | — |
| Akso Health Group | 188 | 0.8x | 0.1x |
| Binah Capital Group, Inc. | 37 | 0.2x | — |
| Kentucky First Federal Bancorp | 35 | 4.0x | 4.0x |
| Pearl Diver Credit Company Inc. | 35 | 1.9x | — |
| Rand Capital Corporation | 32 | 6.2x | — |
| Investcorp Credit Management BDC, Inc. | 24 | 6.3x | 5.3x |
| Equus Total Return, Inc. | 18 | 15.3x | 0.3x |
| Industry Median | 4.0x | 2.1x | |
| (*) Revenue | 8 | ||
| = Enterprise Value | 34 | ||
| (-) Net Debt | -24 | ||
| Equity Value | 58 | ||
| (/) Outstanding shares | 13 | ||
| Fair Price | $4 | ||
Disclaimer: Sweet Value Lab provides estimated intrinsic values for informational purposes only. This is not financial advice. All models rely on assumptions that may not reflect future performance. Always do your own research before making investment decisions.